EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Prognostic Performance of Inflammatory Biomarkers Based on Complete Blood Counts in COVID-19 Patients

Thilo Gambichler iD, Nadine Schuleit, Laura Susok, Jürgen C Becker, Christina H Scheel iD, Christian Torres-Reyes, Oliver Overheu iD, Anke Reinacher-Schick, Wolfgang Schmidt

Viruses · 2023

DOI: 10.3390/v15091920 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Viruses, 2023. Verfasst von Thilo Gambichler und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Ruhr-University, 44791 Bochum, Germany. Hauptthemen laut MEDLINE: COVID-19, Biomarkers, Inflammation. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ruhr-University Bochum.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

With the end of the pandemic, COVID-19 has entered an endemic phase with expected seasonal spikes. Consequently, the implementation of easily accessible prognostic biomarkers for patients with COVID-19 remains an important area of research. In this monocentric study at a German tertiary care hospital, we determined the prognostic performance of different clinical and blood-based parameters in 412 COVID-19 patients. We evaluated the neutrophil-to-lymphocyte ratio (NLR), systemic immune-inflammation index (SII), pan-immune-inflammation value (PIV), and absolute eosinopenia (AEP, 0/µL) of COVID-19 patients (n = 412). The Siddiqui and Mehra staging proposal, the WHO clinical progression scale, and COVID-19-associated death were used as COVID-19 outcome measures. With respect to Siddiqi and Mehra staging, patient age of older than 75 years, high C-reactive protein (CRP), absolute eosinopenia (AEP), cardiovascular comorbidities, and high ferritin were significant independent predictors for severe COVID-19. When outcome was determined according to the WHO clinical progression scale, patient age of older than 75 years, high CRP, high LDH, AEP, high neutrophil-to-lymphocyte ratio (NLR), and the presence of pulmonal comorbidities were significant independent predictors for severe COVID-19. Finally, COVID-19-associated death was predicted independently by patient age of older than 75 years, high LDH, high NLR, and AEP. Eosinopenia (< 40/µL) was observed in 74.5% of patients, and AEP in almost 45%. In conclusion, the present real-world data indicate that the NLR is superior to more complex systemic immune-inflammation biomarkers (e.g., SII and PIV) in COVID-19 prognostication. A decreased eosinophil count emerged as a potential hallmark of COVID-19 infection, whereas AEP turned out to be an accessible independent biomarker for COVID-19 severity and mortality.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19BiomarkersInflammationHumansMaleFemaleAgedPrognosisMiddle AgedBlood Cell CountNeutrophilsSARS-CoV-2Aged, 80 and overSeverity of Illness IndexC-Reactive ProteinLymphocytesAdultGermany

Stichwörter der Autor:innen

C-reactive proteinSARS-CoV-2comorbiditieseosinopeniaeosinophilsferritinlactate dehydrogenasesystemic immune-inflammation

Substanzen

BiomarkersC-Reactive Protein

Autor:innen und Institutionen

  • Department of Dermatology, Ruhr-University, 44791 Bochum, Germany.
  • Department of Dermatology, Christian Hospital Unna, 59423 Unna, Germany.
  • Department of Dermatology, Klinikum Dortmund gGmbH, 44137 Dortmund, Germany.
  • Translational Skin Cancer Research, DKTK Partner Site Essen/Düsseldorf, West German Cancer Center, Dermatology, University Duisburg-Essen, 45122 Essen, Germany.
  • German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.
  • Department of Internal Medicine, Ruhr-University Bochum, 44791 Bochum, Germany.

ORCID-Profile: Thilo Gambichler, Christina H Scheel, Oliver Overheu

Förderung

  • Ruhr-University Bochum

Zitieren

APA

Gambichler, T., Schuleit, N., Susok, L., Becker, J. C., Scheel, C. H., Torres-Reyes, C., Overheu, O., Reinacher-Schick, A., & Schmidt, W. (2023). Prognostic Performance of Inflammatory Biomarkers Based on Complete Blood Counts in COVID-19 Patients. Viruses. https://doi.org/10.3390/v15091920

Vancouver

Gambichler T, Schuleit N, Susok L, Becker JC, Scheel CH, Torres-Reyes C, et al. Prognostic Performance of Inflammatory Biomarkers Based on Complete Blood Counts in COVID-19 Patients. Viruses. 2023. doi:10.3390/v15091920

BibTeX
@article{Gambichler2023,
  author = {Gambichler, Thilo and Schuleit, Nadine and Susok, Laura and Becker, Jürgen C and Scheel, Christina H and Torres-Reyes, Christian and Overheu, Oliver and Reinacher-Schick, Anke and Schmidt, Wolfgang},
  title = {Prognostic Performance of Inflammatory Biomarkers Based on Complete Blood Counts in COVID-19 Patients},
  journal = {Viruses},
  year = {2023},
  doi = {10.3390/v15091920}
}
Kostenlos starten →